Peak detection is a pivotal first step in biomarker discovery from MS data and can significantly influence the results of downstream data analysis steps. We developed a novel automatic peak detection method for prOTOF MS data, which does not require a priori knowledge of protein masses. Random noise is removed by an undecimated wavelet transform and chemical noise is attenuated by an adaptive short-time discrete Fourier transform. Isotopic peaks corresponding to a single protein are combined by extracting an envelope over them. Depending on the S/N, the desired peaks in each individual spectrum are detected and those with the highest intensity among their peak clusters are recorded. The common peaks among all the spectra are identified by choosing an appropriate cut-off threshold in the complete linkage hierarchical clustering. To remove the 1 Da shifting of the peaks, the peak corresponding to the same protein is determined as the detected peak with the largest number among its neighborhood. We validated this method using a data set of serial peptide and protein calibration standards. Compared with MoverZ program, our new method detects more peaks and significantly enhances S/N of the peak after the chemical noise removal. We then successfully applied this method to a data set from prOTOF MS spectra of albumin and albumin-bound proteins from serum samples of 59 patients with carotid artery disease compared to vascular disease-free patients to detect peaks with S/NZ2. Our method is easily implemented and is highly effective to define peaks that will be used for disease classification or to highlight potential biomarkers.
Introduction
MS is increasingly used to detect disease-related biomarkers from human plasma or serum for early diagnosis, prognosis and monitoring of disease progression or response to treatment. Peak detection is a critical early analytical step that will directly influence the identification of potential biomarkers from the MS spectra. Due to the different properties of spectra data from different types of MS instruments, consistency in peak detection methods is essential for data analysis.
MALDI-TOF is one of the most popular MS approaches for detecting proteins or peptides. The prOTOF 2000 (PerkinElmer), an orthogonal MALDI-TOF MS, has high mass accuracy and resolution over a wide mass range, which overcomes many key performance barriers in traditional MALDI-TOFs. However, prOTOF MS spectra show a unique noise pattern in the background. In addition to the random noise normally observed in other high-resolution mass spectra, there are low-frequency noise peaks at 1 Da intervals (Fig. 1A) . The exact source of this noise is unknown but it is hypothesized to originate from the matrix since the matrix is also ionized during the data acquisition process [1] . Removal of this ''chemical noise'' may significantly improve the S/N in prOTOF MS spectra.
Several methods for peak detection in low-resolution MALDI-TOF data have been described [2] [3] [4] [5] . However, for high-resolution data, there are fewer published methods and each is specific to the MS platform used [6] [7] [8] [9] . These methods are all based on the a priori knowledge of the masses of the peptides being queried and are applied to specifically match the known distributions of isotopic peptides in a spectrum. Yu et al. [10] applied a Gaussian filter for smoothing and a Gabor quadrature filter to extract the envelope signal of each peptide. The main benefit of this method is that it combines all the peaks corresponding to one peptide together. However, the Peak alignment is the next step in MS data processing. Several methods have been applied to lower resolution MS data, but these are not applicable to the higher resolution prOTOF data [5, 12] . Johnson et al. [13] applied a closest point matching method in peak alignment. This method is limited by false-positive peak detection. Tibshirani et al. used complete linkage hierarchical clustering that depends on threshold to cut the hierarchical tree [14] . Yu et al. collected all the possible peaks into a super set to find the common peak set among all peak sets as a standard and then aligned all peak sets to the standard using the robust point matching approach in a sequential manner [10] .
Based on these previous analytic approaches, we applied an adaptive, short-time, discrete Fourier transform combined with a wavelet transform to remove ''chemical noise'' and the higher frequency random noise from the prOTOF MS data. All of the single peaks in each spectrum were detected and those peaks corresponding to the same isotopic cluster were combined into an envelope. The desired peaks were then identified based on the S/N threshold. Complete linkage hierarchical clustering was used for peak alignment along all the spectra. The method was validated with a data set with a series of peptide and protein calibration standards. Compared with the wellknown software MoverZ (Genomic Solutions) [15] , it can detect small peaks with high S/Ns. With the chemical noise removal, the peak S/N is greatly enhanced. The proposed peak detection approach (PDA) with chemical noise removal using short-time FFT (stFFT) for prOTOF MS data is abbreviated as PDA_stFFT. Finally, we applied the method to a data set from patients with symptomatic carotid artery atherosclerotic cardiovascular disease to detect peaks with S/NZ2. This paper focuses on the development and validation of PDA_stFFT method for peak detection. The biomarker identification and classification on the patients with carotid artery disease is the subject of a separate communication.
Materials and methods

Sample collection
Serum was obtained for proteomic analysis from a cohort of patients undergoing endarterectomy (EA) for occluded carotid arteries. The study was approved by institutional review board of the National Naval Medical Center, Bethesda, MD, USA. Serum aliquots were stored at À701C until used for this analysis. Patients from these cohorts were divided into four groups: symptomatic EA group (EAS, N 5 12), asymptomatic EA group (EAA, N 5 11), riskfactor-matched control group (RFC, N 5 18) and control group (C, N 5 18). The EAS group was composed of patients who underwent EA surgery with evidence of prior clinical atherosclerotic plaque rupture in the form of a stroke or transient ischemic attack. The EAA group was composed of patients undergoing EA surgery with no clinical evidence of previous plaque rupture. The RFC group included patients without any evidence of atherosclerosis, but with risk factors, such as high cholesterol, smoking history, diabetes and/or hypertension. The C group was patients without any evidence or risk factors for atherosclerosis.
Sample preparation and MS acquisition for clinical samples
The samples were processed by ProXpression Biomarker Enrichment kit (PerkinElmer) according to the manufacturer's protocol. Albumin and albumin-bound proteins were captured by Cibachron blue dye. After binding and washing, the enriched proteins were eluted, concentrated and applied in triplicate directly on MALDI chip targets (PerkinElmer). Mass spectra were acquired with a prOTOF TM 2000 MALDI-O-TOF MS. Mass range for all spectra was set to 700-10 000 Da. The raw data for all spectra were exported in two-column text format for further data processing.
Sample preparation and MS acquisition for peptide and protein standards
To validate the peak detection method, we prepared a mixture of peptide and protein standards with protein calibration standard I and peptide calibration standard II (Bruker Daltonics). The protein or peptide names with their m/z values are listed in Table 1 . Equal volumes of 10 pmol/ mL of both standards in dilution buffer (1% TFA in 50% aqueous ACN) were mixed together to prepare stock solution of 5 pmol/mL peptide and protein standards. The stock solution is then diluted 10 Â with dilution buffer to 500 fmol/mL as starting solution which was further diluted in threefold with dilution buffer to prepare a series of eight diluted standard solutions of 500, 170, 56, 19, 6, 2.1, 0.7 and 0.23 fmol/mL. Mass spectra were acquired with PerkinElmer's prOTOF 2000 within m/z range of 1000-20 000 Da. The instrument was calibrated first according to manufacturer's protocol. In total 1 mL of eight prepared standard solutions was manually spotted on the target in triplicate. Then 1 mL of CHCA matrix is applied to each spot. Total 24 mass spectra were acquired as Ci_01, Ci_02 and Ci_03, i 5 1, 2, y, 8.
Noise modeling and filtering
Assume we have m spectra in study, and each takes on the same equally spaced TOF t k with k 5 1,2,yT, where T is maximum number of m/z points. The intensity of the spectrum j is modeled as:
where s j (t k ) is the true intensity of the spectrum j at TOF t k and x j (t k ) is the observed intensity at TOF t k . In this model, there are two different kinds of noise: c j (t k ), the ''chemical noise'', and n j (t k ), the random noise which mainly results from the limitation of the detector. The ''chemical noise'' has an interval of approximately 1 Da. In typical prOTOF MS, multiple charged peptides are rarely observed, hence we can assume that all peptides or proteins carry a single charge; thus the spacing between the isotopic peaks is 1 Da. We assume that the amplitude of the chemical noise is smaller than that of the true peaks in a local region.
Random noise has very high frequency and can be readily removed with a wavelet transform [2] . We use the undecimated wavelet transform to remove the noise n j (t k ). After computing the wavelet coefficients for the original signal, a hard threshold is applied. The threshold is set to be the product of a threshold parameter and a robust estimate of the noise: the median absolute deviation divided by 0.67. The software used in this study is the Rice Wavelet Toolbox (RWT) (http://www-dsp.rice.edu/software/rwt.shtml). After removing the random noise, the model becomes:
wherex j ðt k Þ is the intensity of the smoothed spectrum j at TOF t k . Now we are left with the smoothed signal with chemical noise.
To identify the true peaks from the smoothed spectrum, the ''chemical noise'' c j (t k ) is removed with a short-time discrete Fourier transform (stDFT). Then the processed MS data set is normalized to correct for the different total amount of proteins desorbed from the sample plate represented by N j . Finally we identify the locations of the desired peaks in each spectrum according to a defined S/N. One of the goals of this study is to remove the chemical noise so that the peaks with comparatively small amplitude can also be detected with high S/N.
As noted, the chemical noise has the property that the spacing between two neighboring peaks is about 1 Da and it has the shape similar to the sinusoidal signal. Hence, we consider using discrete Fourier transform, which is the most popular transform to obtain the information from a signal that is not obviously in the time domain. It decomposes a signal to complex exponential functions of different frequencies and recognizes whether a certain frequency component exists or not in the signal. But it only applies for the stationary signal whose frequency content is unchanged in time. Since transferring the TOF data into m/z follows a formula such as m=z ¼ aðt À t 0 Þ 2 þ b, where a and b are related to the length of the flight tube and the applied voltage, t-t 0 is the flight time, the number of data points in a 1 Da region is different and decreasing from lower m/z to higher m/z. The original DFT cannot be applied directly to the smoothed signal. To analyze the non-stationary signal of which some portion of its signal is stationary, DFT is extended to stDFT. In stDFT, the signal is divided into small enough segments, where each segment of the signal can be where w(k,u) is the window function which is defined as:
wðk; uÞ ¼ 1; if k À uowindow size; 0; otherwise:
with u being the starting point of the window. The window of the stDFT for the smoothed signalx j ðt k Þ is defined as the region in which the number of data points in 1 Da is approximately the same. Fig. 1B shows the number of data points in approximate 1 Da region. Hence, we define the stDFT window as the regions with the same number of data points in 1 Da shown in Fig. 1B . To compute DFT, fast Fourier transform is applied which is an efficient algorithm and reduces the computational complexity from OðT 2 Þ to O(TlogT), where T is the number of data points in the signal.
After stDFT, we restore the sinusoidal signal that has the highest amplitude in the stDFT frequency domain in each window to estimate the chemical noise. When m/z is less than a certain value (about 4000 Da), the smoothed signal x j ðt k Þ has the property that the spacing between peaks is 1 Da. Hence, the estimated chemical noise still has the period of 1 Da. But when m/z becomes larger, undecimated wavelet transform smoothed the spectrum. The restored signal becomes an estimate of the long distance smoothed signal. Figure 1C , D shows the smoothed signal and the estimate of the chemical noise.
To remove the chemical noise from the smoothed signal, we compared the estimated chemical noise with the smoothed signal. Here a hard threshold is applied. If the net signal, defined as the original smoothed signal minus the estimate of the chemical noise, is less than a certain threshold, it is set to be zero. After this step, we are left with an estimate of N j s j ðt k Þ.
Peak identification
After de-noising the signal, we get an estimate of the true intensity in each individual spectrum. Peak identification in each estimated signal is described below.
Normalization of the processed spectrum
In our model, the parameter N j represents the amount of proteins desorbed from the sample plate. This number may vary as the total amount of proteins desorbed from a sample plate may differ between experiments. In order to correct for these differences, we define the total ion current as the mean intensity of the processed spectrum, the number N j . The intensity of the processed spectrum is normalized by dividing it by the total ion current, providing an estimate of the true signal s j (t k ).
Definition of the S/N
S/N is defined as the ratio of the intensity of the true signal s j (t k ) to the background noise. Background noise is considered to be represented by the random noise n j (t k ). The noise level is defined as the mean intensity of the random noise in a certain region.
Peak identification
In the prOTOF data, each protein corresponds to a cluster of peaks that includes all the isotopic peaks. To combine these peaks together, an envelope signal is extracted by fitting a curve to the local maximum points in each 1 Da of the signal s j (t k ). This envelope combines all the peaks corresponding to the same protein into a concave curve. Then the local maximum value of all such concave curves is determined among the cluster of isotope peaks. The m/z of all these local maximums determines the locations of the proteins. This approach differs from some other peak detection methods [6, 7] that detect the monoisotopic peak as the location of the protein. By selecting proper S/N threshold, we can detect the desired peaks. Figure 1E shows the envelope of the normalized signal and the peaks we detected by setting the S/N to be 2. The curve over the denoised signal is the envelope and the circles label the positions of the peaks.
Peak alignment
In the peak detection, we locate the peak in the position where it achieves the highest intensity in its peak cluster. Since the position of the peak that has the highest intensity among its isotope peak cluster for all the spectra may vary about 1 Da, the detected position of the peaks that correspond to the same protein may shift 1 Da left or right too. Thus we need to choose a position that can reflect the proper m/z of the peaks along all the spectra. Before that, we first align the peaks that should correspond to the same m/z since the same peaks can be horizontally shifted within a small region in different spectra. We propose to use the complete linkage hierarchical clustering to do it. This method has been applied in [13] , but for our data set, several points require further explanation.
To do the clustering for all the peaks, the peaks in all the spectra are first ordered into a M Â 1 vector, where M is the total number of peaks in all the spectra. The distance between each two peaks is computed. In complete linkage clustering, the distance between one cluster and another cluster is the greatest distance from any member of one cluster to any member of the other cluster. Here, Euclidian distance is applied. Starting by assigning each item to a cluster, we can find the closest pair of clusters and merge them into a single cluster. Then the distance between the new cluster and each of the old clusters is determined. The process will be repeated till all the clusters are merged. Finally, all the items are clustered into a single cluster of size M. In practice, we do not need all the items to be clustered into a single cluster, so we need to define a proper height to cut the tree to get the desired clustering precision. In [13] , a predefined threshold 0.005 is applied to cut the tree. This value is too large to get a good estimation of the peak position in our data set. If a large threshold is applied, some noisy peaks can be included into the true peaks cluster, which results in the shifting of the positions of the true peaks. In the prOTOF data, the m/z shift is very small. Even when m/z is about 4000 Da, the shifting is still less than 0.2 Da. Thus in our testing, we chose the cutoff threshold to be 0.002.
We estimate the position of the peaks using the mean value of all the peaks in the same cluster. If a peak is a noise peak, the cluster that it belongs to should be very small. Thus, a true peak is identified if the size of the cluster is greater than a certain value. The remaining peaks are considered as noise and not considered further. This results in a series of common peaks along all the spectra.
To find a proper value that can reflect the position where the protein achieves highest intensity, we do the following. For a single peak, if there are no peaks with m/z distance about 1 Da around it, it is considered as the peak. If there are peaks with spacing about 1 Da, we record the number of the peaks and choose the peak that has the largest number as the final peak.
MoverZ software
MoverZ is a program for viewing and manipulating biopolymer mass spectra, capable of performing a wide variety of manual and automated tasks such as peak labeling, calibration, etc. It is an open software and can be downloaded from: http://bioinformatics.genomicsolutions. com/MoverZDL.html. MoverZ contains its own peak-labeling algorithm that uses S/N and resolution as parameters to determine mono-isotopic peaks. First it attempts to assign average masses to all of the peak distributions that have a root-mean-squared S/N greater than a value set by the user. Then it attempts to find a resolved monoisotopic peak in the appropriate position relative to the average mass. The final peaks are determined by a fuzzy logic decision. Further details about MoverZ can be found at http://bioinformatics. genomicsolutions.com/MoverZ.html.
Results
We first validated our method using a data set acquired with a series of peptide and protein calibration standards. Next we showed the results of peak detection and alignment for all the four groups of spectra from the patients with carotid artery disease compared to vascular disease-free patients.
Validation of PDA_stFFT
To validate PDA_stFFT, we tested all the data sets acquired with a series of peptide and protein standards and recorded the S/N of all the known peaks in the peptide and protein standards. The number of peaks detected with PDA_stFFT when S/N is greater than 2 is listed in Table 2 . The S/N for the first replicate (Ci_01, i 5 1, 2, y, 8) is listed in Table 3 . The other two replicates have the similar results. As described in Section 2, the peptide and protein standards were diluted in threefold to prepare a series of eight diluted samples. The peptide and protein concentration for C1 (C1_01 or C1_02 or C1_03) was selected so that we expected to detect all known peaks with prOTOF 2000. As the concentration of peptide and protein was further diluted, we expected the S/N to reduce with dilution. Thus PDA_stFFT will detect fewer peaks as the dilution increases or no peak as the concentration of peptide or protein fails below the detection limit of the instrument. The data in Table 2 reflect this pattern. Figure 2A shows the three raw spectra around the peak with m/z 757 Da in sample C1_0i, i 5 1, 2, 3 and Fig. 2B shows the S/N of the denoised signal with smoothing and chemical noise removal. Figure 2C is the same as Fig. 2B without the chemical noise removal. From Fig. 2B , we can see that the S/N is enhanced significantly after the chemical noise removal.
Comparison between PDA_stFFT and MoverZ
To see the efficiency of our method, PDA_stFFT, we compared the total number of the peaks detected with PDA_stFFT and MoverZ. Table 2 summarizes the number of peaks with S/NZ2 detected with PDA_stFFT and MoverZ. Among all the cases, except in the sample C1_01, our method detects more peaks than MoverZ. This may be due to the removal of chemical noise, which enhances the S/N of the peak. The S/N for a peak obtained with our method is much larger than that with MoverZ in most cases. We list the S/N of all the peaks in the sample C1_01, C1_02 and C1_03 in Table 1 as an example. Similar results were achieved with other data sets. In Table 1 , ''None'' means the S/N is smaller than 2 in that position. When m/z is small, the S/N calculated with our method can be several times as that with MoverZ. When m/z becomes very large, MoverZ may detect the peaks with higher S/N than PDA_stFFT. This is because the detection sensitivity of prOTOF 2000 decreases with the increase of m/z, and the peak intensity of a true signal becomes weaker when m/z is very large. Since the chemical noise in high m/z region is similar to that in low m/z region, after the chemical noise removal, the signal may become even weaker, which may make the S/N smaller.
One advantage of PDA_stFFT over MoverZ is that it can discern some small peaks from the chemical noise. Figure 2A shows a peak at m/z 757, which belongs to the peptide ''Bradykinin fragment 1-7 (m/z 757 Da)''. PDA_stFFT detected this peak with a high S/N while MoverZ failed to detect it as summarized in Table 1 . Bradykinin fragment 1-7 in C1_01, C1_02 and C1_03 was detected by PDA_stFFT as a peak with S/N of 101.9, 61.9 and 33.1, respectively ( Fig. 2A) . However, MoverZ only detected 757 Da peak in C1_01 with S/N of 2.3 and failed to detect 757 Da peak in C1_02 and C1_03.
Results of peak detection on the clinical sample data set
In the wavelet transform, the threshold parameter was set to six, allowing smoothing of the signal. During the chemical noise removal, the threshold for determining the chemical noise is set to 80 percentiles of the value obtained by subtracting the estimated chemical noise from the smoothed signal in each adaptive region. If the number of peaks in one cluster is more than 15% of the number of spectra in one group in the peak alignment step, we take it as the true peak, and get the position of the peak by computing the mean m/z over all the peaks in its peak cluster. Otherwise, we consider them noise peaks. Before the peak identification step, it is necessary to remove the outlier or noise data using the unsupervised information. To find the noise data, the mean of all the spectra is determined. If the mean value of the spectrum ranges between mean minus the deviation and mean plus the deviation, we consider the spectrum acceptable for further analysis. For example, the EAS group has 12 patients and 11 patients have three replicate spectra and one patient has two replicate spectra. Within these 35 spectra, one spectrum was found to be an outlier and was removed from the data set. A total 894 of common peaks were detected from these 34 spectra after the alignment from 12 265 detected peaks. After we combined the peaks that may correspond to the same protein together by choosing the peak with the maximum number in its neighborhood, 519 peaks were defined for further analysis.
Although the peaks aligned well ( Figure 3A) , there was a shift in a very small region. We aligned the peaks with the complete linkage clustering and determined the position of each common peak as the average position. To show the peak alignment and detection processes, we focused on the region between 1700 and 1900 Da of the spectra. Fig. 3B shows all the peaks detected and the aligned peaks between 1700 and 1900 Da. In total, 677 peaks were detected and 41 peaks defined as common peaks. After combining the peaks that correspond to the same protein together, 24 peaks were defined (Fig. 3C with the solid line) . Figure 3D shows all the smoothed spectra in this region and the detected peaks. The vertical lines correspond to the peaks detected by PDA_stFFT after alignment and the final determined peaks are pointed out in the Fig. 3D with label of ''Final peak''.
As observed in Fig. 3D , the PDA_stFFT can detect very small peaks, such as m/z 1762, 1833 and 1835 with S/NZ2. From the two enlarged regions within Fig. 3D , two to three detected peaks (with a vertical line at center of the peak) are 1 Da apart and these peaks may correspond to the same protein. Fig. 3E , F shows the peaks detected in these two small regions. The m/z 1762 peak was determined as the final peak from the peak cluster between m/z 1760 and 1765 and two peaks of m/z 1833 and 1835 were determined as final two peaks between m/z 1831 and 1839. These three peaks are plotted as solid lines in Fig. 3E and F. The peaks with dotted lines in Fig. 3E and F are considered to be isotopic peaks.
With the same setting, we finally are able to detect 465 peaks in the EAA group, 589 peaks in the control group and 334 peaks in the RFC group. These peaks will be used for classification of a disease model to find any potential biomarker or panel of biomarkers that can distinguish difference among the groups.
Discussion
Peak detection plays an essential role in biomarker discovery from MS data. The peak detection method, however, depends significantly on the property of the data. An automatic peak detection method is proposed in this paper for prOTOF data. Random noise is removed by the undecimated wavelet transform. We have designed an adaptive stDFT to address chemical noise removal, which increases the S/N of the true peaks. The possible isotopic peaks corresponding to one protein are combined together by extracting an envelope over them. Depending on S/N, the desired peaks in each individual spectrum can be identified. In contrast to other methods for identifying peptides, this method is independent of the knowledge of the mass of the peptides. In addition, since we use the stDFT transform to remove the chemical noise, it can be applied to a wide range of mass. The final peaks are determined by choosing the peak, which has the largest number among its neighbors with a distance of about 1 Da in the aligned common peaks obtained by complete linkage hierarchical clustering for all the peaks detected in all the spectra. We believe this approach can be easily implemented and is very effective.
We validated our PDA_stFFT method with a data set acquired with an analysis of the peptide and protein calibration standards. The results are consistent with our experiment settings. The S/N for known peaks is significantly increased after chemical noise removal. Compared with the popular software MoverZ, our method can detect more peaks in diluted samples and can detect peaks with low intensity with high S/N. Finally, we successfully applied our method to detect the peaks from the spectra of a large data set derived from clinical serum samples.
